Home Services Projects Software Resources Publications About Contact
Nicosia, Cyprus · Athens, Greece

Data-Driven Science,
Built by Scientists

NovaMechanics is a pioneering SME at the intersection of cheminformatics, nanoinformatics, AI, and computational modelling — accelerating drug discovery and materials innovation since 2009.

20+
Years of Expertise
50+
R&D Projects
500+
AI Models Deployed
100+
Research Publications

Bridging Computation and Discovery

NovaMechanics Ltd applies state-of-the-art mathematical techniques for the creation, implementation, and interpretation of validated predictive models — spanning big data analysis, personalized medicine, clinical trials, computer-aided drug discovery, and materials science.

Our goal is to increase profitability, decrease risk, and reduce experimental cost in the process of designing and producing new materials or drugs by conceiving new modelling ideas and performing simulations, testing, and validation procedures.

With headquarters in Nicosia, Cyprus and operations in Athens, Greece, we develop cutting-edge software tools, predictive models, and cloud-based platforms that transform how researchers approach scientific challenges.

Drug Discovery

Computer-aided design of small molecules for diseases including cancer, arthritis, thalassaemia, and more

Materials Science

Safe-by-design approaches to nanomaterials and advanced materials development

AI & Informatics

Cheminformatics, bioinformatics, and nanoinformatics powered by machine learning

Cloud Platforms

SaaS tools making advanced analytics accessible to researchers worldwide

Mission & Vision

Democratizing advanced analytics and accelerating scientific innovation for researchers and organizations worldwide.

Our Mission

Bridge the gap between disease targets and optimal drug candidates with significantly lower costs and increased potential. Make cutting-edge AI, machine learning, and predictive modelling accessible to everyone.

Our Vision

A world where computational methods and AI empower every scientist to make better, faster, and safer decisions — from molecular design to clinical application, from materials discovery to regulatory compliance.

Our Approach

Created by scientists, for scientists. We combine deep domain expertise in chemistry, biology, and materials science with state-of-the-art AI and software engineering to deliver solutions that work the way researchers do.

Our Team

A multidisciplinary team of PhD scientists, researchers, and engineers pushing the boundaries of computational science.

AA

Antreas Afantitis

managing director / head of machine learning & ai
AT

Andreas Tsoumanis

managing director (gr) / head of it
TP

Tassos Papadiamantis

head of data, ai ethics & fairification
KP

Kostas Papavasileiou

head of drug discovery / cheminformatics
PK

Panagiotis Kolokathis

head of materials informatics
DM

Dimitris Mintis

head of operations (cy)
DZ

Danae Zareifi

head of bioinformatics
HT

Haralampos Tzoupis

team leader - molecular simulations

Software & SaaS Products

Industry-leading tools for cheminformatics, predictive modelling, and data analytics.

Isalos Analytics

No-code desktop analytics platform for data preparation, statistical analysis, machine learning, AutoML, and DOE. Available on Windows, macOS, and Linux.

Learn more

Enalos Cloud Platform

AI-powered cheminformatics and nanoinformatics web services. Access 500+ predictive models for drug discovery, materials design, and safety assessment — free of charge.

Learn more

Enalos Suite

Standalone, platform-independent software packaging any predictive model developed by NovaMechanics. Custom-made solutions for your specific research needs.

Learn more

Enalos+ KNIME Nodes

Comprehensive cheminformatics and nanoinformatics functionalities integrated into the KNIME analytics platform for big data analysis and drug discovery.

Learn more

Our Offices

Nicosia, Cyprus

Athens, Greece

Let's Work Together

Whether you need computational support, a research partner for an EU proposal, or custom software solutions — we'd love to hear from you.